8 medicines held by Bioprojet Pharma on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Anapen 300 micrograms in 0.3ml solution for injection in a pre-filled syringe PA22580/001/002 |
Epinephrine | Bioprojet Pharma | Marketed |
| Anapen 500 micrograms/0.3ml solution for injection in a pre-filled syringe PA22580/001/003 |
Epinephrine | Bioprojet Pharma | Marketed |
| Anapen Junior 150 micrograms in 0.3ml solution for injection in a pre- filled syringe PA22580/001/001 |
Epinephrine | Bioprojet Pharma | Marketed |
| Hidrasec Infants and Children 4 mg/mL Oral Suspension PA22580/002/001 |
Racecadotril | Bioprojet Pharma | Not marketed |
| Ozawade 18 mg film-coated tablets EU/1/21/1546/002-003 |
Pitolisant hydrochloride | Bioprojet Pharma | — |
| Ozawade 4.5 mg film-coated tablets EU/1/21/1546/001 |
Pitolisant hydrochloride | Bioprojet Pharma | — |
| Wakix 18 mg film-coated tablets EU/1/15/1068/002 |
Pitolisant hydrochloride | Bioprojet Pharma | — |
| Wakix 4.5 mg film-coated tablets EU/1/15/1068/001 |
Pitolisant hydrochloride | Bioprojet Pharma | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.